Efficacy and Safety Study of ABT-288 in Subjects With Mild-to-Moderate Alzheimer's Disease

NCT01018875 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

242

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: ABT-288
DRUG: donepezil
DRUG: placebo

Sponsor

AbbVie (prior sponsor, Abbott)